Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

de Souza A, Westra J, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Kallenberg CG.

Arthritis Res Ther. 2013;15(5):R104.

2.

Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?

de Souza AW, Abdulahad WH, Sosicka P, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Westra J, Kallenberg CG.

Clin Exp Immunol. 2014 Nov;178(2):270-8. doi: 10.1111/cei.12422.

3.

High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations.

Bruchfeld A, Wendt M, Bratt J, Qureshi AR, Chavan S, Tracey KJ, Palmblad K, Gunnarsson I.

Mol Med. 2011 Jan-Feb;17(1-2):29-35. doi: 10.2119/molmed.2010.00132. Epub 2010 Sep 10.

4.

Association of circulating level of high mobility group box 1 with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.

Wang C, Gou SJ, Chang DY, Yu F, Zhao MH, Chen M.

Arthritis Care Res (Hoboken). 2013 Nov;65(11):1828-34. doi: 10.1002/acr.22187.

5.

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.

Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2011 May 6;13(3):R71. doi: 10.1186/ar3332.

6.

Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis.

De'Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD.

Am J Kidney Dis. 1995 Mar;25(3):380-9.

PMID:
7872315
7.

Circulating neutrophil gelatinase-associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis.

Chen M, Wang F, Zhao MH.

Rheumatology (Oxford). 2009 Apr;48(4):355-8. doi: 10.1093/rheumatology/ken500. Epub 2009 Jan 30.

PMID:
19181656
8.

The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.

Zhang Y, Shi W, Tang S, Li J, Yin S, Gao X, Wang L, Zou L, Zhao J, Huang Y, Shan L, Gounni AS, Wu Y, Yuan F, Zhang J.

Arthritis Res Ther. 2013 Oct 24;15(5):R161. doi: 10.1186/ar4344.

9.

Urinary levels of high mobility group box-1 are associated with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.

Ma TT, Wang H, Wang C, Chang DY, Zhao MH, Chen M.

PLoS One. 2015 Apr 17;10(4):e0123586. doi: 10.1371/journal.pone.0123586. eCollection 2015.

10.

High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins.

de Souza AW, van der Geest KS, Brouwer E, Pinheiro FA, Oliveira AC, Sato EI, Andrade LE, Bijl M, Westra J, Kallenberg CG.

Arthritis Res Ther. 2015 Jun 12;17:158. doi: 10.1186/s13075-015-0672-8.

11.

Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.

Simon A, Subra JF, Guilpain P, Jeannin P, Pignon P, Blanchard S, Garo E, Jaillon S, Chevailler A, Renier G, Puéchal X, Bottazzi B, Mantovani A, Delneste Y, Augusto JF.

PLoS One. 2016 Jan 21;11(1):e0147091. doi: 10.1371/journal.pone.0147091. eCollection 2016.

12.

Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides.

Terrier B, Saadoun D, Sène D, Ghillani P, Amoura Z, Deray G, Fautrel B, Piette JC, Cacoub P.

Ann Rheum Dis. 2009 Oct;68(10):1564-71. doi: 10.1136/ard.2008.094714. Epub 2008 Oct 28.

PMID:
18957481
13.

Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.

Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.

PLoS One. 2017 Oct 10;12(10):e0185880. doi: 10.1371/journal.pone.0185880. eCollection 2017.

14.

Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.

Yamaguchi M, Ando M, Kato S, Katsuno T, Kato N, Kosugi T, Sato W, Tsuboi N, Yasuda Y, Mizuno M, Ito Y, Matsuo S, Maruyama S.

J Rheumatol. 2015 Oct;42(10):1853-60. doi: 10.3899/jrheum.141622. Epub 2015 Sep 15.

PMID:
26373560
15.

Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.

Söderberg D, Kurz T, Motamedi A, Hellmark T, Eriksson P, Segelmark M.

Rheumatology (Oxford). 2015 Nov;54(11):2085-94. doi: 10.1093/rheumatology/kev217. Epub 2015 Jul 12.

16.

Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.

Sacri AS, Chambaraud T, Ranchin B, Florkin B, Sée H, Decramer S, Flodrops H, Ulinski T, Allain-Launay E, Boyer O, Dunand O, Fischbach M, Hachulla E, Pietrement C, Le Pogamp P, Stephan JL, Belot A, Nivet H, Nobili F, Guillevin L, Quartier P, Deschênes G, Salomon R, Essig M, Harambat J.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i104-12. doi: 10.1093/ndt/gfv011. Epub 2015 Feb 12.

PMID:
25676121
17.

Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.

Córdova-Sánchez BM, Mejía-Vilet JM, Morales-Buenrostro LE, Loyola-Rodríguez G, Uribe-Uribe NO, Correa-Rotter R.

Clin Rheumatol. 2016 Jul;35(7):1805-16. doi: 10.1007/s10067-016-3195-z. Epub 2016 Feb 6.

PMID:
26852317
18.

Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.

Kawasaki A, Hasebe N, Hidaka M, Hirano F, Sada KE, Kobayashi S, Yamada H, Furukawa H, Yamagata K, Sumida T, Miyasaka N, Tohma S, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.

PLoS One. 2016 May 11;11(5):e0154393. doi: 10.1371/journal.pone.0154393. eCollection 2016.

19.

Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.

Ohlsson SM, Pettersson Å, Ohlsson S, Selga D, Bengtsson AA, Segelmark M, Hellmark T.

Clin Exp Immunol. 2012 Oct;170(1):47-56. doi: 10.1111/j.1365-2249.2012.04633.x.

20.

Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ.

Arthritis Rheum. 2012 Oct;64(10):3452-62. doi: 10.1002/art.34562.

Supplemental Content

Support Center